American Oncology Network, Inc. (AONC)
OTCMKTS · Delayed Price · Currency is USD
10.00
0.00 (0.00%)
Aug 6, 2026, 9:30 AM EST
American Oncology Network Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,744 | 1,266 | 1,138 | 938.24 | 714.68 |
Other Revenue | 15.51 | 13.47 | 11.74 | 5.51 | 10.07 |
| 1,759 | 1,279 | 1,150 | 943.75 | 724.74 | |
Revenue Growth | 37.55% | 11.27% | 21.82% | 30.22% | 126.56% |
Cost of Revenue | 1,639 | 1,194 | 1,052 | 863.47 | 651.79 |
Gross Profit | 120.48 | 85.51 | 98.1 | 80.28 | 72.95 |
Selling, General & Admin | 136.57 | 103.43 | 89.25 | 79.37 | 50.88 |
Operating Expenses | 136.57 | 103.43 | 89.25 | 79.37 | 50.88 |
Operating Income | -16.09 | -17.92 | 8.84 | 0.91 | 22.07 |
Interest Expense | -7.06 | -6.42 | -3.42 | -1.42 | -1.12 |
Interest & Investment Income | 3.2 | 1.33 | 0.15 | 0.13 | 0.03 |
Earnings From Equity Investments | 0.15 | -0.26 | - | - | - |
Other Non Operating Income (Expenses) | -3.84 | -8.26 | 0.29 | 0.74 | 0.18 |
EBT Excluding Unusual Items | -23.64 | -31.53 | 5.87 | 0.36 | 21.17 |
Merger & Restructuring Charges | -1.34 | -31.24 | -3.28 | - | - |
Other Unusual Items | 0.51 | 27.08 | -2.59 | 0.11 | - |
Pretax Income | -24.46 | -35.69 | - | 0.46 | 21.17 |
Income Tax Expense | 2.5 | 0.38 | - | 0.46 | -0.78 |
Earnings From Continuing Operations | -26.96 | -36.07 | - | - | 21.95 |
Minority Interest in Earnings | 22.99 | 30.53 | - | - | - |
Net Income | -3.97 | -5.54 | - | - | 21.95 |
Preferred Dividends & Other Adjustments | 5.55 | 3.58 | - | - | 2.52 |
Net Income to Common | -9.52 | -9.12 | - | - | 19.43 |
Net Income Growth | - | - | - | - | 629.87% |
Shares Outstanding (Basic) | 14 | 7 | - | - | - |
Shares Outstanding (Diluted) | 38 | 7 | - | - | - |
Shares Change | 460.99% | - | - | - | - |
EPS (Basic) | -0.69 | -1.36 | - | - | - |
EPS (Diluted) | -0.89 | -1.36 | - | - | - |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -25.9 | -30.4 | -13.98 | -34.66 | 25.02 |
Free Cash Flow Per Share | -0.69 | -4.55 | - | - | - |
Gross Margin | 6.85% | 6.69% | 8.53% | 8.51% | 10.07% |
Operating Margin | -0.92% | -1.40% | 0.77% | 0.10% | 3.04% |
Profit Margin | -0.54% | -0.71% | - | - | 2.68% |
Free Cash Flow Margin | -1.47% | -2.38% | -1.22% | -3.67% | 3.45% |
EBITDA | -5.58 | -9.47 | 15.56 | 6.99 | 25.73 |
EBITDA Margin | -0.32% | -0.74% | 1.35% | 0.74% | 3.55% |
D&A For EBITDA | 10.52 | 8.45 | 6.72 | 6.08 | 3.66 |
EBIT | -16.09 | -17.92 | 8.84 | 0.91 | 22.07 |
EBIT Margin | -0.91% | -1.40% | 0.77% | 0.10% | 3.04% |
Effective Tax Rate | - | - | - | 100.00% | - |
Revenue as Reported | 1,759 | 1,279 | 1,150 | 943.75 | 724.74 |